Geode Capital Management LLC Purchases 20,547 Shares of Encompass Health Co. (NYSE:EHC)

Geode Capital Management LLC increased its holdings in Encompass Health Co. (NYSE:EHC - Free Report) by 1.2% during the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,673,610 shares of the company's stock after purchasing an additional 20,547 shares during the quarter. Geode Capital Management LLC owned 1.66% of Encompass Health worth $161,781,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also added to or reduced their stakes in EHC. UMB Bank n.a. lifted its position in shares of Encompass Health by 387.7% during the 3rd quarter. UMB Bank n.a. now owns 317 shares of the company's stock valued at $31,000 after acquiring an additional 252 shares during the last quarter. V Square Quantitative Management LLC lifted its holdings in shares of Encompass Health by 53.0% during the third quarter. V Square Quantitative Management LLC now owns 404 shares of the company's stock valued at $39,000 after purchasing an additional 140 shares during the last quarter. Avior Wealth Management LLC acquired a new position in shares of Encompass Health in the 3rd quarter valued at $40,000. Benjamin F. Edwards & Company Inc. increased its stake in Encompass Health by 58.9% in the 2nd quarter. Benjamin F. Edwards & Company Inc. now owns 534 shares of the company's stock worth $46,000 after purchasing an additional 198 shares in the last quarter. Finally, Point72 Asia Singapore Pte. Ltd. acquired a new stake in Encompass Health during the 2nd quarter worth about $58,000. 97.25% of the stock is owned by institutional investors and hedge funds.

Encompass Health Stock Down 0.5 %

Shares of NYSE EHC traded down $0.47 during mid-day trading on Monday, reaching $97.72. 790,086 shares of the company traded hands, compared to its average volume of 639,341. The company's fifty day moving average is $99.35 and its two-hundred day moving average is $92.61. The company has a debt-to-equity ratio of 0.88, a quick ratio of 1.04 and a current ratio of 1.04. Encompass Health Co. has a fifty-two week low of $65.39 and a fifty-two week high of $104.55. The stock has a market cap of $9.85 billion, a PE ratio of 23.72, a price-to-earnings-growth ratio of 1.34 and a beta of 0.86.

Encompass Health (NYSE:EHC - Get Free Report) last released its quarterly earnings results on Monday, October 28th. The company reported $1.03 EPS for the quarter, beating analysts' consensus estimates of $0.94 by $0.09. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The company had revenue of $1.35 billion for the quarter, compared to analyst estimates of $1.33 billion. During the same quarter last year, the firm posted $0.86 earnings per share. The company's quarterly revenue was up 11.9% compared to the same quarter last year. On average, analysts expect that Encompass Health Co. will post 4.29 earnings per share for the current year.

Encompass Health Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Wednesday, January 15th. Investors of record on Thursday, January 2nd will be paid a dividend of $0.17 per share. This represents a $0.68 annualized dividend and a yield of 0.70%. The ex-dividend date is Thursday, January 2nd. Encompass Health's payout ratio is currently 16.43%.

Analyst Ratings Changes

A number of research firms have recently issued reports on EHC. KeyCorp boosted their price target on shares of Encompass Health from $115.00 to $117.00 and gave the company an "overweight" rating in a report on Tuesday, October 29th. Barclays raised their price objective on Encompass Health from $109.00 to $116.00 and gave the stock an "overweight" rating in a research report on Tuesday, October 29th. UBS Group upped their target price on Encompass Health from $100.00 to $110.00 and gave the company a "buy" rating in a report on Wednesday, September 25th. Truist Financial reaffirmed a "buy" rating and set a $116.00 price objective (up from $108.00) on shares of Encompass Health in a research report on Wednesday, October 30th. Finally, Royal Bank of Canada lifted their target price on shares of Encompass Health from $105.00 to $110.00 and gave the company an "outperform" rating in a research note on Wednesday, October 30th. Nine equities research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company's stock. According to MarketBeat.com, Encompass Health currently has an average rating of "Buy" and an average target price of $107.11.

Encompass Health Company Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.